UBS Group Cuts AdaptHealth (NASDAQ:AHCO) Price Target to $11.00

AdaptHealth (NASDAQ:AHCO - Free Report) had its price target reduced by UBS Group from $12.00 to $11.00 in a research report sent to investors on Thursday,Benzinga reports. UBS Group currently has a buy rating on the stock.

A number of other analysts also recently issued reports on AHCO. Royal Bank of Canada reduced their price target on shares of AdaptHealth from $13.00 to $11.00 and set an "outperform" rating on the stock in a report on Tuesday, November 19th. Robert W. Baird reduced their target price on AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a report on Wednesday, November 6th. Truist Financial reduced their price objective on AdaptHealth from $13.00 to $12.00 and set a "buy" rating on the stock in a research note on Friday, November 15th. Finally, Canaccord Genuity Group reduced their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Wednesday, November 6th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $12.20.

AdaptHealth Price Performance

Shares of AdaptHealth stock traded down $0.15 on Thursday, hitting $8.78. 721,079 shares of the company traded hands, compared to its average volume of 858,720. The stock has a market capitalization of $1.18 billion, a P/E ratio of -5.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth has a 52 week low of $7.01 and a 52 week high of $11.90. The business has a 50-day simple moving average of $9.93 and a 200 day simple moving average of $10.25.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently added to or reduced their stakes in the stock. Assetmark Inc. bought a new position in shares of AdaptHealth during the 4th quarter valued at approximately $28,000. Blue Trust Inc. increased its position in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after purchasing an additional 1,115 shares during the last quarter. Quarry LP increased its position in AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company's stock valued at $67,000 after acquiring an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in AdaptHealth by 15.4% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after acquiring an additional 1,690 shares during the last quarter. Finally, CIBC Asset Management Inc bought a new position in AdaptHealth during the third quarter valued at $122,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.